JP Morgan analyst maintains Neutral rating on DocuSign with $81 price forecast ahead of earnings report. Upside potential and ...

DocuSign remains a 'Buy' with a $95 target. See more on DOCU stock's international growth, AI integration, and strong ...

Q1 2026 Earnings Call Transcript June 6, 2025 Operator: Good afternoon, ladies and gentlemen. Thank you for joining ...

DocuSign's Q1'26 earnings beat estimates, showcasing 30% FCF margins and raised outlook. Find out why I am upgrading DOCU ...

Also Read: JPMorgan Bullish On Hewlett Packard Enterprise’s Future, Cites ‘Durable’ Non-AI Segments, Capital Returns He continues to sense a more balanced risk-reward profile for DocuSign in ...

The analysts continue to view the stock as a Buy/High-Risk investment, citing future opportunities in IAM, operating leverage, and a broad market potential. In other recent news, Docusign Inc. has ...

The analysts emphasized that while the transition ahead may be uncertain, the risk and reward ... maintaining its position as a market leader. In other recent news, DocuSign Inc (NASDAQ:DOCU).

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Investors are cheering signs of a potential truce in the acrimonious feud between President Trump and Elon Musk, and a ...

Docusign shares were down 17% at $757.58 in early trading following its earnings, released after the market closed on ...